Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment

This publication has 32 references indexed in Scilit:

• Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action
  British Journal of Haematology, 1998
• Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
  The American Journal of Medicine, 1996
• The Tissue Factor Pathway: How It Has Become a “Prima Ballerina”
  Thrombosis and Haemostasis, 1995
• The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor
  Thrombosis Research, 1991
• Purification and properties of heparin-releasable lipoprotein- associated coagulation inhibitor
  Blood, 1991
• Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.
  Proceedings of the National Academy of Sciences, 1990
• Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)
  Thrombosis Research, 1988
• Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation
  Blood, 1987
• Characterization of the inhibition of tissue factor in serum
  Blood, 1987
• Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.
  Proceedings of the National Academy of Sciences, 1977